Description
Zopidaily (Zopiclone) 7.5 mg
Zopidaily 7.5 mg is a brand name associated with zopiclone, a prescription hypnotic medicine used for short-term management of insomnia. Available product information for zopiclone 7.5 mg confirms it is intended for adults and is not recommended for long-term continuous use.
Active Ingredient and Medicine Class
The verified active ingredient is zopiclone. It belongs to the cyclopyrrolone group of hypnotics, sometimes grouped with “Z-drugs” used for sleep disorders.
Established Medical Uses
Zopiclone is established for the short-term treatment of insomnia in adults, including difficulty falling asleep, night-time awakening, and early morning awakening. Regulatory product information also notes use in transient, situational, or chronic insomnia when symptoms are severe or debilitating.
How It Works
Zopiclone acts on the central GABA receptor complex and enhances inhibitory signalling in the brain, which helps induce and maintain sleep. Product information states that it has hypnotic, sedative, anxiolytic, anticonvulsant, and muscle-relaxant actions.
Important Safety Information
Zopiclone is contraindicated in patients with hypersensitivity to zopiclone or any excipients, severe respiratory insufficiency, severe hepatic insufficiency, sleep apnoea syndrome, and myasthenia gravis. Product information also warns about dependence, tolerance, withdrawal symptoms, and the need to avoid prolonged use. Caution is advised in older adults, people with liver or kidney impairment, and those with respiratory disease.
Clinically significant interactions can occur with other central nervous system depressants, including alcohol, opioids, sedatives, anxiolytics, antipsychotics, antidepressants, and anticonvulsants, because of additive sedation and psychomotor impairment. Zopiclone is also metabolised mainly by CYP3A4, so inhibitors of this enzyme may increase exposure.
Possible Side Effects
Commonly reported adverse effects include bitter taste, dry mouth, drowsiness, dizziness, and next-day impairment. Important serious reactions can include confusion, unusual behavioural changes, falls, respiratory depression, dependence, withdrawal effects, and complex sleep-related behaviours.
Scientific Evidence
Clinical reviews and trials support zopiclone as an effective short-term hypnotic that can reduce sleep latency and improve sleep continuity. Evidence also suggests that tolerability is generally acceptable, although bitter taste and sedation remain notable adverse effects and long-term safety data are less certain.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet, prescribing information, or individual professional assessment.
Medical Sources
- Flamingo Pharma (UK) Ltd. Zopiclone 7.5mg film-coated tablets, Summary of Product Characteristics. Official prescribing information
- Buscemi N, et al. “Zopiclone to treat insomnia in older adults: A systematic review.” European Neuropsychopharmacology (2021). PubMed
